Polly A. Murphy, Director at Atea Pharmaceuticals, holds 92.14K shares in Atea Pharmaceuticals (Ticker: AVIR), holds 5.00K shares in Celcuity (Ticker: CELC). Most recently, Polly A. Murphy Bought ― shares of Atea Pharmaceuticals on May 20, 2026 for an estimated value of $25.44K.
What is the percentage of profitable transactions made by Polly A. Murphy?
The percentage of profitable transactions made by Polly A. Murphy is 67%.
What is the average return per transaction made by Polly A. Murphy?
The average return per transaction made by Polly A. Murphy is 3.00%.
What stocks does Polly A. Murphy hold?
Polly A. Murphy holds: AVIR, CELC stocks.
What was Polly A. Murphy’s latest transaction?
Polly A. Murphy latest transaction was an Informative Buy of $25.44K.
What was Polly A. Murphy's most profitable transaction?
Polly A. Murphy’s most profitable transaction was an Informative Buy of CELC stock on November 23, 2022. The return on the trade was 44.00%.
What is Polly A. Murphy's role in Atea Pharmaceuticals?
Polly A. Murphy's role in Atea Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.